LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

LLY

1,032.74

-1.19%↓

JNJ

205.41

+0.03%↑

ABBV

230.3

+2.63%↑

UNH

340.48

+4.8%↑

AZN

90.84

+0.7%↑

Начало・Списък с акции・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Затворен

СекторЗдравеопазване

37.02 2.89

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

36.12

Максимум

37.05

Ключови измерители
By Trading Economics
Приходи	11M 51M
Продажби	39M 239M
P/E Средно за сектора	11.202 79.874
EPS	1.08
Марж на печалбата	21.242
Служители	268
EBITDA	14M 73M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+29.54% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	358M 2B
Предишно отваряне	34.13
Предишно затваряне	37.02

Настроения в новините

By Acuity

44%

56%

145 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bullish Evidence

29.8 / N/A Подкрепа & съпротива

Harmony Biosciences Holdings Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.12.2025 г., 17:29 ч. UTC

Значими двигатели на пазара

Придобивния, сливания и поглъщания

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2.12.2025 г., 16:21 ч. UTC

Печалби

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2.12.2025 г., 16:18 ч. UTC

Печалби

Correction to Scotiabank Quarterly Earnings Buoyed Article

2.12.2025 г., 23:53 ч. UTC

Пазарно говорене

Nikkei May Rise After Gains on Wall Street -- Market Talk

2.12.2025 г., 22:48 ч. UTC

Печалби

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2.12.2025 г., 22:12 ч. UTC

Пазарно говорене

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2.12.2025 г., 22:03 ч. UTC

Пазарно говорене

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

2.12.2025 г., 22:00 ч. UTC

Пазарно говорене

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2.12.2025 г., 21:56 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.12.2025 г., 21:44 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 21:38 ч. UTC

Пазарно говорене

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2.12.2025 г., 21:19 ч. UTC

Печалби

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2.12.2025 г., 20:06 ч. UTC

Пазарно говорене

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2.12.2025 г., 19:55 ч. UTC

Пазарно говорене

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2.12.2025 г., 19:53 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

2.12.2025 г., 19:53 ч. UTC

Пазарно говорене

Печалби

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2.12.2025 г., 19:24 ч. UTC

Пазарно говорене

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2.12.2025 г., 19:06 ч. UTC

Пазарно говорене

Precious Metals Step Back After Silver Sets Record -- Market Talk

2.12.2025 г., 18:27 ч. UTC

Придобивния, сливания и поглъщания

Kraken to Acquire Backed Finance AG

2.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.12.2025 г., 15:17 ч. UTC

Пазарно говорене

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2.12.2025 г., 14:47 ч. UTC

Пазарно говорене

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2.12.2025 г., 14:38 ч. UTC

Пазарно говорене

Silver Steps Back From Record Levels -- Market Talk

2.12.2025 г., 14:31 ч. UTC

Пазарно говорене

Печалби

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Harmony Biosciences Holdings Inc Прогноза

Ценова цел

By TipRanks

29.54% нагоре

12-месечна прогноза

Среден 46 USD 29.54%

Висок 62 USD

Нисък 32 USD

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Harmony Biosciences Holdings Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

10 ratings

Купи

Задържане

Продай

Според 10 анализатори, дали борсови рейтинги на Harmony Biosciences Holdings Inc през последните 3 месеца.

Техническа оценка

By Trading Central

29.8 / N/AПодкрепа & съпротива

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Настроение

By Acuity

145 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.